PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Cyclopentolate hydrochloride - Painful Ciliary Spasm

PAD Profile : Cyclopentolate hydrochloride - Painful Ciliary Spasm

Brand Names Include :
Minims

Traffic Light Status

Status 1 of 1.

Status :
Blue
Important
Formulations :
  • Eye drops
  • Eye drops (preservative free, unit dose)
Important Information :
Eye drops 0.5%, 1%. Transfer to primary care may be suitable after a minimum of 2 months supply from the specialist.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
05 September 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Prescribing Clinical Network recommends the use of cyclopentolate eye drops (0.5% & 1%) for the treatment of painful ciliary spasm in blind eyes

Cyclopentolate eye drops will be considered to be BLUE (no information sheet) on the traffic light system.

Initiation will be by consultant ophthalmologists and transfer of care can be considered after a minimum of 2 months prescribing by the consultant and once the patient has shown to be benefiting from treatment.

Associated BNF Codes

11. Eye
11.05.00. Mydriatics and cycloplegics
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More